| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |